Neurodegenerative Disease Management
Blood-based biomarkers in the anti-amyloid era of Alzheimer's disease: clinical utility, implementation challenges, and future directions
ReviewBiomarkers
- Alzheimer's disease
- Amyloid-related imaging abnormalities
- Dementia
- Aβ42/Aβ40 ratio
- Glial fibrillary acidic protein
- Humans
The paper
Kaohsiung Medical University
Neurodegenerative Disease Management, 26 Sep 2026
